Manipal Heart Failure Registry (MHFR)
Launched by MANIPAL UNIVERSITY · May 15, 2017
Trial Information
Current as of May 03, 2025
Unknown status
Keywords
ClinConnect Summary
RESEARCH GAPS IDENTIFIED:
Only a couple of registry studies in India have followed patients for not more than one year and therefore long-term data on disease management and healthcare resource utilization and health economics has never addressed adequately. Typically, these studies have focused primarily upon inpatient HF clinical profiles, where detailed long-term documentation of cardiac function, treatment patterns, and outcomes is lacking.
HYPOTHESES:
Long term follow up of heart failure patients can identify the disease characteristics, clinical outcomes and help in the development...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients 18 year old, and above
- • 2. Patients with a documented diagnosis of Acute heart failure (or chronic heart failure with acute exacerbations) as decided by the physician according to local practices and their clinical judgment (i.e., History/examination; Chest X-ray; ECG, Echocardiogram, BNP or NT-proBNP).
- Exclusion Criteria:
- • 1. Patient's participation in any other clinical trial with an investigational treatment.
- • 2. Use of investigational drugs within 5 half-lives of enrolment, or until the expected pharmacodynamic effect has returned to baseline, whichever is longer (as guideline, last dose for small molecules should have occurred more than 30 days, and for biologics more than 4 months prior to enrolment).
About Manipal University
Manipal University is a prestigious higher education institution in India, renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, Manipal University leverages its extensive resources and expertise in medical and health sciences to advance clinical research. The university fosters collaboration among multidisciplinary teams to conduct rigorous clinical trials, aiming to enhance patient care and contribute to the global body of medical knowledge. With a focus on ethical practices and regulatory compliance, Manipal University is dedicated to improving health outcomes through evidence-based research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manipal, Karnataka, India
Patients applied
Trial Officials
Tom Devasia, MD, DM, FACC
Study Chair
Manipal University
Ajit Singh, PHARM D, PhD
Principal Investigator
Manipal University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials